AmarnaBio’s focus is unlocking the therapeutic and diagnostic potential of RNAs. We leverage machine learning and -omics integration to decode regulatory networks orchestrated by RNA interactomes. Our mission is to deliver novel biomarker and drug target candidates to address diseases of high unmet need, providing partners with tools to accelerate drug development and improve patient outcomes. This innovative approach positions us as a leader in the next generation of RNA-based diagnostics and therapeutics, offering unparalleled value to biopharma companies and clinical researchers seeking to enhance treatment efficacy and patient outcomes.
Company Details
- Founded
- -
- Address
- Diseases Of High Unmet Need
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Mississauga.
Amarnabio Questions
Amarnabio's LinkedIn profile is https://www.linkedin.com/company/amarnabio
Amarnabio's industry is
Biotechnology Research
Amarnabio's top competitors are
Esignglobal,
Fareva,
The Pangaea Group,
Osmos,
金蝶软件(中国)有限公司,
Founderscard,
Manali Petrochemicals Ltd..
Amarnabio's categories are Biotechnology Research
Amarnabio's founding year is 2024
